Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
AIDS (London, England)|March 19, 2019
Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocationJames B Maurice, Lucy Garvey, Emmanuel A Tsochatzis, et al.Neurology|February 26, 2016
Neuroinflammation in treated HIV-positive individuals: A TSPO PET studyJaime H Vera, Qi Guo, James H Cole, et al.Frontiers in Immunology|February 2, 2023
Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantationSarah Gleeson, Paul Martin, Tina Thomson, et al.Journal of the American Society of Nephrology : JASN|August 1, 2020
High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic ScreeningCandice Clarke, Maria Prendecki, Amrita Dhutia, et al.Annals of the Rheumatic Diseases|August 7, 2021
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppressionMaria Prendecki, Candice Clarke, Helena Edwards, et al.The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.Cytometry. Part B, Clinical Cytometry|June 28, 2024
European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantationPeter Kelleher, Louise Greathead, Liam Whitby, et al.Journal of Immunological Methods|June 15, 2011
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trialsHarry Kaltsidis, Hannah Cheeseman, Jakub Kopycinski, et al.Eclinicalmedicine|September 15, 2022
Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipientsTina Thomson, Maria Prendecki, Sarah Gleeson, et al.The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.Pageof 7